Home | Publications | Research (R&D) | Pipeline place holder
place holder place holder

Pipeline


HeartWare Limited Product Pipeline Analysis


Publication Date   August 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   42
ISBN Number   not applicable
Product Code   GMD657
Ask a question about this product?

Price £505.00

approximately: $753 | €602

Summary


This report is an insightful source for data, analysis and strategic insights into a HeartWare Limited's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content


  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Financial Performance
    • 2.4 Industry Outlook - Cardiovascular Devices
  • 3 Business Description
    • 3.1 Business Overview
    • 3.2 Major Products and Services
      • 3.2.1 Overview
  • 4 History
  • 5 Competitors
  • 6 Key Employees
  • 7 Key Employee Biographies
  • 8 Company Statement
  • 9 Locations And Subsidiaries
    • 9.1 Head Office
    • 9.2 Other Locations & Subsidiaries
  • 10 Recent Developments
    • 10.1 Strategy And Business Planning
      • 10.1.1 Apr 18, 2008: HeartWare Moves To New Manufacturing Facility In US
    • 10.2 Financial Announcements
      • 10.2.1 Apr 18, 2008: HeartWare Reports 2007 Results
      • 10.2.2 Aug 31, 2007: HeartWare Reports H1 2007 Results
      • 10.2.3 Feb 28, 2007: HeartWare Reports 2006 Results
    • 10.3 Corporate Communications
      • 10.3.1 Apr 30, 2008: HeartWare Appoints New Board Member
      • 10.3.2 Apr 29, 2008: HeartWare Appoints CMO
      • 10.3.3 Sep 04, 2006: HeartWare Appoints New CEO
    • 10.4 Product News
      • 10.4.1 May 05, 2008: HeartWare Receives Conditional Approval Of IDE
      • 10.4.2 Jul 13, 2007: Heartware Announces Clinical Trial Update
      • 10.4.3 Mar 09, 2007: Heartware Ltd To Launch HVAD Heart Device In Europe
      • 10.4.4 May 22, 2006: HeartWare Receives Regulatory Approval For HVAD Implants In United Kingdom
    • 10.5 Product Approvals
      • 10.5.1 May 05, 2008: HeartWare Receives Conditional Approval Of IDE
      • 10.5.2 May 22, 2006: HeartWare Receives Regulatory Approval For HVAD Implants In United Kingdom
    • 10.6 Clinical Trials
      • 10.6.1 Jul 13, 2007: Heartware Announces Clinical Trial Update
  • 11 HeartWare Limited Pipeline Products
    • 11.1 HeartWare Limited Product Pipeline Analysis
      • 11.1.1 HeartWare Limited Pipeline Products By Equipment Type
      • 11.1.2 HeartWare Limited Pipeline Products By Development Stage
      • 11.1.3 HeartWare Limited Pipeline Products By Therapy Area
      • 11.1.4 HeartWare Limited Pipeline Products By Clinical Trials
      • 11.1.5 HeartWare Limited Pipeline Products By News Summary
    • 11.2 HVAD System
      • 11.2.1 Product Description
      • 11.2.2 Product Status
      • 11.2.3 Clinical Trials
      • 11.2.4 Product Milestone
      • 11.2.5 Product Patent Details
    • 11.3 MVAD System
      • 11.3.1 Product Description
      • 11.3.2 Product Status
      • 11.3.3 Product Patent Details
    • 11.4 HeartWare IV-VAD
      • 11.4.1 Product Description
      • 11.4.2 Product Status
      • 11.4.3 Product Patent Details
    • 11.5 PedVAD
      • 11.5.1 Product Description
      • 11.5.2 Product Status
    • 11.6 TETS Technology
      • 11.6.1 Product Description
      • 11.6.2 Product Status
  • 12 Appendix
    • 12.1 Methodology
      • 12.1.1 Coverage
      • 12.1.2 Secondary Research
      • 12.1.3 Primary Research
      • 12.1.4 Expert Panel Validation
    • 12.2 Contact Us
    • 12.3 About Global Markets Direct
    • 12.4 Disclaimer
  • 1 List of Tables
    • Table 1: HeartWare Limited,Key Facts
    • Table 2: HeartWare Limited, Key Employees,
    • Table 3: HeartWare Limited, Other Locations
    • Table 4: HeartWare Limited Pipeline Products by Equipment Type
    • Table 5: HeartWare Limited Pipeline Products By Development Stage
    • Table 6: HeartWare Limited Pipeline Products By Therapy Area
    • Table 7: HeartWare Limited Pipeline Products By Clinical Trials
    • Table 8: HeartWare Limited Pipeline Products By News Summaries
    • 1.2 List of Figures
    • Figure 1: HeartWare Limited Pipeline Products By Development Stage
    • Figure 2: HeartWare Limited Pipeline Products By News Summary
    • Figure 3: Global Markets Direct Methodology